Psykey, Inc. (OTCMKTS:CEOS) Short Interest Down 98.4% in December

Psykey, Inc. (OTCMKTS:CEOS) was the recipient of a significant decline in short interest in December. As of December 15th, there was short interest totalling 2,400 shares, a decline of 98.4% from the November 30th total of 149,000 shares. Based on an average daily volume of 2,072,800 shares, the days-to-cover ratio is presently 0.0 days.

Psykey Stock Up 3.1 %

Shares of CEOS traded up $0.00 during midday trading on Thursday, reaching $0.03. 1,320,150 shares of the stock were exchanged, compared to its average volume of 609,697. Psykey has a 12-month low of $0.01 and a 12-month high of $0.05. The firm has a 50 day simple moving average of $0.02 and a 200-day simple moving average of $0.02.

About Psykey

Psykey, Inc engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market.